help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 44, No. 3 499-506
doi:10.1210/jcem-44-3-499
Copyright © 1977 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ISMAIL-BEIGIY, F.
Right arrow Articles by RAHIMIFAR, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ISMAIL-BEIGIY, F.
Right arrow Articles by RAHIMIFAR, M.

A Variant of Iodotyrosine-Dehalogenase Deficiency

F. ISMAIL-BEIGIY* and M. RAHIMIFAR

Department of Internal Medicine and Pahlavi Bio-Medical Research Unit, Pahlavi University Shiraz, Iran

Three siblings (products of consanguineous marriage) affected with iodotyrosinedehalogenase deficiency (presumed homozygotes) were found to have low thyroxine and large multinodular goiters, but none was mentally retarded. Iodide therapy corrected the serum T4 and thyroidal iodide uptake and discharge curve. The goiters shrank with iodide treatment. The subjects demonstrated significant ability to deiodinate intravenously injected L-mono-iodotyrosine (MIT) but not L-diiodotyrosine (DIT); 9.9% and 80.0% of an injected dose of 125I-MITand 125I-DIT appeared unchanged in the urine in 4 h, respectively. The data in presumed heterozygote subjects (both parents and two other siblings) were intermediate between controls and affected subjects. Thyroidal dehalogenase activity was measured in one of the affected subjects in vitro. The tissue showed greater ability to deiodinate MIT than DIT, but both activities were much lower than that of control tissue.

The disease appears to be transmitted in an autosomal recessive fashion. The MIT-dehalogenase activity demonstrable in the affected individuals may explain the mild phenotype, in that MIT leaking from the goiter can be deiodinated to a significant degree and the liberated iodide reutilized.

Supported by grants from Pahlavi University Research Council and The Iran Foundation.

* To whom reprint requests should be addressed.

Received June 24, 1976.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. Afink, W. Kulik, H. Overmars, J. de Randamie, T. Veenboer, A. van Cruchten, M. Craen, and C. Ris-Stalpers
Molecular Characterization of Iodotyrosine Dehalogenase Deficiency in Patients with Hypothyroidism
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4894 - 4901.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society